| Previous Close | 0.052 |
| Open | 0.052 |
| Bid | 0.000 x |
| Ask | 0.000 x |
| Day's Range | 0.052 - 0.052 |
| 52 Week Range | 0.050 - 0.100 |
| Volume | 198 |
| Avg. Volume | 14,049 |
| Market Cap | 1.95M |
| Beta | 2.24 |
| PE Ratio (TTM) | 0.63 |
| EPS (TTM) | 0.08 |
| Earnings Date | N/A |
| Dividend & Yield | 0.00 (0.00%) |
| Ex-Dividend Date | 2014-11-28 |
| 1y Target Est | 1.00 |
- Motley Fool•last year
Is It Time to Buy Illumina Inc. Stock?
It's been a tough year so far for the genomic sequencing leader's stock. Are better days ahead?
- Motley Fool•last year
Illumina Inc. Reports Q4 Earnings Decline
Higher costs of revenue hurt the genomic sequencing company in the fourth quarter.
- Zacks•2 years ago
Gilead Tops Q4 Earnings Estimates, 2015 Outlook Disappoints - Analyst Blog
Gilead Sciences, Inc.'s (GILD) fourth-quarter earnings (including stock-based compensation expenses) of $2.38 per share.
